Literature DB >> 27810686

Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: An analysis based on the Korea National Diabetes Program Cohort.

Sang Ouk Chin1, Sang Youl Rhee2, Suk Chon2, Sei Hyun Baik3, Yongsoo Park4, Moon Suk Nam5, Kwan Woo Lee6, Ki Hong Chun7, Jeong-Taek Woo2, Young Seol Kim8.   

Abstract

AIM: Although hypoglycemia is associated with cognitive dysfunction, including dementia, in patients with type 2 diabetes mellitus (DM), the data are equivocal. The purpose of this study was to investigate the association between hypoglycemia, dementia, and other cognitive dysfunctions.
METHODS: This was a prospective observational study based upon the Korea National Diabetes Program (KNDP). Among the 4540 participants in the KNDP cohort, individuals aged ⩾60years without any history of hypoglycemia or cognitive dysfunction (n=1957) were included. Nationally representative data from the Health Insurance Review and Assessment Service of Korea claim database were used to obtain a more precise determination of patient outcome.
RESULTS: During a mean follow-up period of 3.4±0.9years, 118 subjects experienced hypoglycemia-related events. The incidence of dementia and cognitive dysfunction was 7.5 cases per 1000 person-years (PY) and 0.61 cases per 1000 PY, respectively. In the subjects who experienced hypoglycemic events (relative to those who did not), the incidence of dementia was significantly higher (P=0.0139), but the incidence of cognitive dysfunction was not (P=0.1106). Hypoglycemic events were associated with dementia (HR, 2.689; 95% CI, 1.080-6.694, P=0.0335) following multiple adjustments. There was also a significant linear trend toward an increased dementia risk commensurate with an increasing number of hypoglycemic events (P=0.0286).
CONCLUSIONS: Hypoglycemia is significantly associated with the risk of dementia in Korean type 2 DM patients aged ⩾60years.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dementia; Hypoglycemia; Type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27810686     DOI: 10.1016/j.diabres.2016.09.027

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  19 in total

Review 1.  Cognitive Frailty in Older People with Type 2 Diabetes Mellitus: the Central Role of Hypoglycaemia and the Need for Prevention.

Authors:  A H Abdelhafiz; A J Sinclair
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

Review 2.  Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?

Authors:  Corey J Frank; Ewan C McNay
Journal:  J Neuroendocrinol       Date:  2021-12-13       Impact factor: 3.627

Review 3.  Prevalence of Moderate to Severe Anxiety Symptoms among Patients with Myocardial Infarction: a Meta-Analysis.

Authors:  Yajun Lian; Jingsha Xiang; Xiaoyan Wang; Atipatsa C Kaminga; Wenhang Chen; Zhiwei Lai; Wenjie Dai; Jianzhou Yang
Journal:  Psychiatr Q       Date:  2021-05-19

4.  Cognition, serum BDNF levels, and BDNF Val66Met polymorphism in type 2 diabetes patients and healthy controls.

Authors:  Yan-Feng Zhen; Xing-Yu Liu; Dong-Hao Zhou; Xiangdong Du; Guangzhong Yin; Yingyang Zhang; Hui Fang; Gang Xu; Jair C Soares; Xiang Yang Zhang
Journal:  Oncotarget       Date:  2017-12-16

Review 5.  Hypoglycemia and Dementia.

Authors:  Sang Youl Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2017-06

6.  Comparative Effectiveness for Glycemic Control in Older Adults with Diabetes.

Authors:  Michael Quartuccio; Brian Buta; Rita R Kalyani
Journal:  Curr Geriatr Rep       Date:  2017-07-28

Review 7.  Monotherapy in Patients with Type 2 Diabetes Mellitus.

Authors:  Sang Youl Rhee; Hyun Jin Kim; Seung Hyun Ko; Kyu Yeon Hur; Nan Hee Kim; Min Kyong Moon; Seok O Park; Byung Wan Lee; Kyung Mook Choi; Jin Hwa Kim
Journal:  Diabetes Metab J       Date:  2017-10       Impact factor: 5.376

8.  Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies.

Authors:  Xue Zhao; Qing Han; You Lv; Lin Sun; Xiaokun Gang; Guixia Wang
Journal:  Oncotarget       Date:  2017-12-14

Review 9.  Monotherapy in patients with type 2 diabetes mellitus.

Authors:  Sang Youl Rhee; Hyun Jin Kim; Seung-Hyun Ko; Kyu Yeon Hur; Nan-Hee Kim; Min Kyong Moon; Seok-O Park; Byung-Wan Lee; Kyung Mook Choi; Jin Hwa Kim
Journal:  Korean J Intern Med       Date:  2017-10-23       Impact factor: 2.884

10.  Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis.

Authors:  Jacqueline M McMillan; Bria S Mele; David B Hogan; Alexander A Leung
Journal:  BMJ Open Diabetes Res Care       Date:  2018-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.